HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Erskine Selected Research

Daniel Erskine Research Topics

Disease

11Parkinson Disease (Parkinson's Disease)
08/2023 - 01/2019
10Dementia (Dementias)
12/2022 - 06/2017
6Synucleinopathies
01/2022 - 01/2019
4Lewy Body Disease (Lewy Body Dementia)
12/2022 - 12/2019
3Cognitive Dysfunction
01/2022 - 09/2017
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2017
2Mitochondrial Diseases (Mitochondrial Disease)
06/2023 - 01/2023
2Gliosis
01/2023 - 01/2016
2Diffuse Cerebral Sclerosis of Schilder (Alpers' Disease)
01/2023 - 10/2022
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 01/2022
2Multiple System Atrophy
01/2020 - 01/2019
2Hallucinations (Hallucination)
06/2017 - 01/2016
1Drug Resistant Epilepsy
01/2023
1Neurologic Manifestations (Neurological Manifestations)
01/2023
1Sudden Unexpected Death in Epilepsy
10/2022
1Epilepsy (Aura)
10/2022
1Globoid Cell Leukodystrophy (Krabbe Disease)
01/2022
1Sensorineural Hearing Loss
01/2022
1Neuroinflammatory Diseases
01/2022
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2022
1Atrophy
01/2022
1Stroke (Strokes)
01/2022
1Inflammation (Inflammations)
01/2022
1Hypertension (High Blood Pressure)
12/2021
1Rare Diseases (Rare Disease)
10/2021
1Disease Progression
01/2021
1Schizophrenia (Dementia Praecox)
12/2019
1Nervous System Diseases (Neurological Disorders)
12/2019
1Mental Disorders (Mental Disorder)
12/2019
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2019
1Demyelinating Diseases (Demyelinating Disease)
01/2019
1Wallerian Degeneration
09/2017

Drug/Important Bio-Agent (IBA)

14SynucleinsIBA
12/2022 - 06/2017
9Proteins (Proteins, Gene)FDA Link
08/2023 - 09/2017
5Biomarkers (Surrogate Marker)IBA
11/2022 - 09/2017
4AntibodiesIBA
01/2022 - 01/2019
3Mitochondrial DNA (mtDNA)IBA
01/2023 - 01/2022
2Serine (L-Serine)FDA Link
12/2022 - 01/2020
2Amyloid (Amyloid Fibrils)IBA
01/2019 - 01/2016
1Glial Fibrillary Acidic ProteinIBA
01/2023
1Calbindin 2IBA
10/2022
1ParvalbuminsIBA
10/2022
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
10/2022
1CalbindinsIBA
10/2022
1Single-Domain AntibodiesIBA
01/2022
1PrionsIBA
01/2022
1Psychosine (Galactosylsphingosine)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1SphingolipidsIBA
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2022
1AntigensIBA
01/2022
1alpha-SynucleinIBA
01/2022
1Apolipoproteins E (ApoE)IBA
12/2021
1Monoclonal AntibodiesIBA
01/2020
1EpitopesIBA
01/2020
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
12/2019
1Cholinergic Agents (Cholinergics)IBA
12/2019
1Blood Proteins (Serum Proteins)IBA
01/2019
1Fibrinogen (Factor I)FDA Link
01/2019
1Peptide Hydrolases (Proteases)FDA Link
09/2017
1Myelin-Associated GlycoproteinIBA
09/2017
1CalpainIBA
09/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Retinaldehyde (Retinal)IBA
01/2016

Therapy/Procedure

4Therapeutics
06/2023 - 01/2019
1Immunotherapy
01/2020